U.S. Forest Service scientists believe an Oregon State University graduate student working on a cooperative project with the agency’s Pacific Southwest Research station on the Tahoe National Forest has photographed a wolverine, an animal whose presence has not been confirmed in California since the 1920s.

Katie Moriarty, a wildlife biology student, was conducting research on another carnivore called the American marten when a remote-controlled camera she set photographed the animal on February 28, 2008. Forest Service scientists who are experts at detecting rare carnivores believe the photographed animal is a wolverine.

The North American wolverine is the largest member of the weasel family. Adult males weigh 26 to 40 pounds, while females are 17 to 26 pounds.

LAUSANNE, Switzerland, March 7 /PRNewswire/ --

Galderma Pharma, S.A. announces an agreement with ZARS Pharma, Inc. giving Galderma exclusive rights for all markets outside the USA and Canada for promotion and distribution of a novel topical anesthetic cream. This partnership follows an agreement signed last year between Galderma and ZARS Pharma for the promotion and distribution of Pliaglis(TM) in the USA and Canada.

LONDON, March 7 /PRNewswire/ -- Cannabis-derived medicines may one day be used in the treatment of Alzheimer's disease which affects 417,000 people in the UK.

Professor Raphael Mechoulam of the Hebrew University of Jerusalem, Israel, will present new findings to a group of international experts at a Cannabinoids Medicines Symposium to be held at the Royal Pharmaceutical Society of Great Britain (RPSGB) in London on Monday, 10 March. The research, still at an early stage, indicates that memory loss, the main symptom of Alzheimer's, can be slowed down significantly in mice by some of the chemicals present in cannabis. The next step will be to initiate human trials to see if the same effect can be achieved on the human brain.

LONDON, March 7 /PRNewswire/ --

- Acquisition Will Strengthen ERP Vendor's Position in Key Vertical Markets

This is a revised release of "Solarsoft Business Systems to Acquire Chelford Group plc" distributed over PR Newswire at 10:07, today 7th March. Please note the additional text starting from the paragraph beginning 'The Directors of Solarsoft'.

Solarsoft Business Systems announced today that the board of Chelford Group plc ("Chelford") has agreed to recommend an offer by Solarsoft Acquisition Limited ("Solarsoft") to acquire Chelford.

In the latest issue of Nature Biotechnology, EuroStemCell scientist Elena Cattaneo from University of Milano along with Mauro Toselli from University of Pavia, Elisabetta Cerbai from the University of Florence and Ferdinando Rossi of University of Torino have challenged findings published in the same journal last year that amniotic fluid-derived stem cells can produce cells of the nervous system.

Amniotic fluid is the liquid that surrounds the fetus during pregnancy.

Scientists in Japan have discovered a new species of bacteria, Microbacterium hatanonis, that can live in hairspray, according to the results of a study published in the March issue of the International Journal of Systematic and Evolutionary Microbiology.

“Contamination of cosmetic products is rare but some products may be unable to suppress the growth of certain bacteria,” says Dr Bakir from the Japan Collection of Microorganisms, Saitama, Japan. “We discovered a new species of bacteria called Microbacterium hatanonis, which we found contaminates hairspray.

Growing concern over increased levels of atmospheric carbon dioxide has prompted new interest in techniques for removing the gas from the smokestacks of such large-scale sources as coal-fired electric power plants. But to minimize their economic impact, the cost of adding such controls must be minimized so they don’t raise the price of electricity significantly.

Researchers have developed a new, low-cost material called hyperbranched aluminosilica for capturing carbon dioxide (CO2) from the smokestacks of coal-fired power plants and other generators of the greenhouse gas.

Transfer RNA is an ancient molecule, central to every task a cell performs and thus essential to all life. A new study from the University of Illinois indicates that it is also a great historian, preserving some of the earliest and most profound events of the evolutionary past in its structure.

Of the thousands of RNAs so far identified, transfer RNA (tRNA) is the most direct intermediary between genes and proteins. Like many other RNAs (ribonucleic acids), tRNA aids in translating genes into the chains of amino acids that make up proteins. With the help of a highly targeted enzyme, each tRNA molecule recognizes and latches onto a specific amino acid, which it carries into the protein-building machinery.

The discovery of the brain’s so-called melanocortin system and its central role in controlling appetite has paved the way for entirely new possibilities for treating obesity and anorexia. In the latest issue of the prestigious journal Nature Reviews Drug Discovery, Uppsala University researcher Jarl Wikberg and one of his associates present a review of pioneering research in this field that he and other scientists have conducted over nearly two decades.

The mapping of the melanocortin system was made possible by the cloning of genes for five different melanocortin receptors, which was performed by Jarl Wikberg in collaboration with other researchers in the early 1990s.

DES PLAINES, Illinois, March 7 /PRNewswire/ --

- Abbott's FISH Technology Provides Analytical Tool with Potential to Assess Clinical Response to Lung Cancer Treatment in Patients with Non-Small-Cell Lung Cancer

Abbott (NYSE: ABT) today announced that its molecular diagnostics business has entered into an agreement with Genentech, Inc., F. Hoffmann-La Roche Ltd. and OSI Pharmaceuticals, Inc. to develop a gene test to potentially assess the clinical benefit of Tarceva(R) (erlotinib), an oral tablet indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.